uPA and uPAR in fibrinolysis, immunity and pathology
- 1 August 2004
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 25 (8) , 450-455
- https://doi.org/10.1016/j.it.2004.06.004
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- The soluble D2D388-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesionJournal of Cell Science, 2004
- Urokinase-Deficient Mice Fail To Generate a Type 2 Immune Response following Schistosomal Antigen ChallengeInfection and Immunity, 2004
- Plasminogen activator inhibitor type–1 deficiency does not influence the outcome of murine pneumococcal pneumoniaBlood, 2003
- Fibrin-mediated Protection Against Infection-stimulated ImmunopathologyThe Journal of Experimental Medicine, 2003
- Urokinase Regulates Vitronectin Binding by Controlling Urokinase Receptor OligomerizationJournal of Biological Chemistry, 2002
- Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivoBlood, 2001
- Structure, Function and Expression on Blood and Bone Marrow Cells of the Urokinase‐Type Plasminogen Activator Receptor, uPARThe International Journal of Cell Cloning, 1997
- Cell‐Surface Acceleration of Urokinase‐Catalyzed Receptor CleavageEuropean Journal of Biochemistry, 1997
- Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.Journal of Clinical Investigation, 1996
- Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator.Journal of Clinical Investigation, 1996